The use of fluorescent dyes and probes in surgical oncology

European Journal of Surgical Oncology

Volumn 36, Issue 1, 2010, Pages 6-15

  te Velde, E A ^a   Veerman, Th ^a   Subramaniam, V ^b   Ruers, Th ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Fluorescent; Oncology; Probe; Resection; Sentinel node; Surgery

Indexed keywords

ALEXA FLUOR 750; CATHEPSIN B; CETUXIMAB; CHLORIN E6; CHLOROTOXIN; CY 5 5; CY 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER; HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMIN 800; INDOCYANINE GREEN; IRDYE 800 CW; METHYLENE BLUE; OREGON 488; PROSENSE 680; PROSENSE 750; PYRO 2 DEOXYGLUCOSE; QUANTUM DOT; TECHNETIUM SULFUR COLLOID TC 99M; TM 601; TRASTUZUMAB; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANALGESIA; AUTOFLUORESCENCE; BINDING AFFINITY; BLEACHING; CANCER MODEL; CANCER PATIENT; CANCER SURGERY; CELL METABOLISM; CLINICAL TRIAL; CONTRAST; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DOSE REDUCTION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG SOLUBILITY; FALSE NEGATIVE RESULT; FLUORESCENCE ANALYSIS; HUMAN; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTUM YIELD; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SIGNAL NOISE RATIO; SPECTRAL SENSITIVITY; TARGET ORGAN;

ANIMALS; BIOLOGICAL MARKERS; COLORING AGENTS; CONTRAST MEDIA; FLUORESCENT DYES; HUMANS; INDOCYANINE GREEN; NEOPLASMS; SENTINEL LYMPH NODE BIOPSY;

EID: 73249152374     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.10.014     Document Type: Review

References (77)

1. Kovar J.L., Simpson M.A., Schutz-Geschwender A., et al. A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Anal Biochem 367 (2007) 1-12
2. Licha K. Contrast agents for optical imaging. Top Curr Chem 222 (2002) 1-29
3. Osterman H.L., and Schutz-Geschwender A. Seeing beyond the visible with IRDye infrared dyes. LI-COR Biosci (2007) 1-8
4. Frangioni J.V. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7 (2003) 626-634
5. Kairdolf B.A., Mancini M.C., Smith A.M., et al. minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatized surface coatings. Anal Chem 80 (2008) 3029-3034
6. Lim Y.T., Kim S., Nakayama A., et al. Selection of quantum dot wavelengths for biomedical assays and imaging. Mol Imaging 2 (2003) 50-64
7. Ohnishi S., Lomnes S.J., Laurence R.G., et al. Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging 4 (2005) 172-181
8. Jaffer F.A., Libby P., and Weissleder R. Molecular imaging of cardiovascular disease. Circulation 116 (2007) 1052-1061
9. Nakayama A., Bianco A.C., Zhang C.Y., et al. Quantitation of brown adipose tissue perfusion in transgenic mice using near-infrared fluorescence imaging. Mol Imaging 2 (2003) 37-49
10. Bentzen E.L., Tomlinson I.D., Mason J., et al. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjug Chem 16 (2005) 1488-1494
11. Sevick-Muraca E.M., Houston J.P., and Gurfinkel M. Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr Opin Chem Biol 6 (2002) 642-650
12. Benya R., Quantana J., and Brundage B. Adverse reactions to indocyanine green: a case report and a review of the literature. Cathet Cardiovasc Diagn 17 (1989) 231-233
13. Ogata F., Azuma R., Kikuchi M., et al. Novel lymphography using indocyanine green dye for near-infrared fluorescence labeling. Ann Plast Surg 58 (2007) 652-655
14. Hilger I., Leistner Y., Berndt A., et al. Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol 14 (2004) 1124-1129
15. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114 (2006) 165-172
16. Borotto E., Englender J., Pourny J.C., et al. Detection of the fluorescence of GI vessels in rats using a CCD camera or a near-infrared video endoscope. Gastrointest Endosc 50 (1999) 684-688
17. Detter C., Russ D., Iffland A., et al. Near-infrared fluorescence coronary angiography: a new noninvasive technology for intraoperative graft patency control. Heart Surg Forum 5 (2002) 364-369
18. Taggart D.P., Choudhary B., Anastasiadis K., et al. Preliminary experience with a novel intraoperative fluorescence imaging technique to evaluate the patency of bypass grafts in total arterial revascularization. Ann Thorac Surg 75 (2003) 870-873
19. Herbort C.P., LeHoang P., and Guex-Crosier Y. Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard angiographic protocol. Ophthalmology 105 (1998) 432-440
20. Chen S.J., Lee A.F., Lee F.L., et al. Indocyanine green angiography of central serous chorioretinopathy. Zhonghua Yi Xue Za Zhi (Taipei) 62 (1999) 605-613
21. Haglund M.M., Hochman D.W., Spence A.M., et al. Enhanced optical imaging of rat gliomas and tumor margins. Neurosurgery 35 (1994) 930-940
22. Raabe A., Beck J., Gerlach R., et al. Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow. Neurosurgery 52 (2003) 132-139
23. Aoki T., Yasuda D., Shimizu Y., et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World J Surg 32 (2008) 1763-1767
24. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
25. cox C.E., Pendas S., Cox J.M., et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227 (1998) 651-653
26. Schirrmeister H., Kotzerke J., Vogl F., et al. Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients. Cancer Biother Radiopharm 19 (2004) 784-790
27. Alazraki N.P., Eshima D., Eshima L.A., et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 27 (2008) 55-67
28. Soltesz E.G., Kim S., Kim S.W., et al. Sentinel lymph node mapping of the gastrointestinal tract by using invisible light. Ann Surg Oncol 13 (2006) 386-396
29. Tanaka E., Choi H.S., Fujii H., et al. Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 13 (2006) 1671-1681
30. Motomura K., Inaji H., Komoike Y., et al. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol 29 (1999) 604-607
31. Kitai T., Inomoto T., Miwa M., et al. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12 (2005) 211-215
32. Tagaya N., Yamazaki R., Nakagawa A., et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 195 (2008) 850-853
33. Sevick-Muraca E.M., Sharma R., Rasmussen J.C., et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 246 (2008) 734-741
34. Ogasawara Y., Ikeda H., Takahashi M., et al. Evaluation of breast lymphatic pathways with indocyanine green fluorescence imaging in patients with breast cancer. World J Surg 32 (2008) 1924-1929
35. Fujiwara M., Mizukami T., Suzuki A., et al. Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. J Plast Reconstr Aesthetic Surg (2008)
36. Kusano M., Tajima Y., Yamazaki K., et al. Sentinel node mapping guided by indocyanine green fluorescence imaging: a new method for sentinel node navigation surgery in gastrointestinal cancer. Dig Surg 25 (2008) 103-108
37. Miyashiro I., Miyoshi N., Hiratsuka M., et al. Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: comparison with infrared imaging. Ann Surg Oncol 15 (2008) 1640-1643
38. Noura S., Ohue M., Seki Y., et al. Evaluation of the lateral sentinel node by indocyanine green for rectal cancer based on micrometastasis determined by reverse transcriptase-polymerase chain reaction. Oncol Rep 20 (2008) 745-750
39. Swart P.J., Beljaars L., Kuipers M.E., et al. Homing of negatively charged albumins to the lymphatic system: general implications for drug targeting to peripheral tissues and viral reservoirs. Biochem Pharmacol 58 (1999) 1425-1435
40. Parungo C.P., Ohnishi S., Kim S.W., et al. Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 129 (2005) 844-850
41. Troyan S.L., Kianzad V., Gibbs-Strauss S.L., et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16 10 (2009) 2943-2952
42. Hama Y., Koyama Y., Urano Y., et al. Two-color lymphatic mapping using Ig-conjugated near infrared optical probes. J Invest Dermatol 127 (2007) 2351-2356
43. Josephson L., Mahmood U., Wunderbaldinger P., et al. Pan and sentinel lymph node visualization using a near-infrared fluorescent probe. Mol Imaging 2 (2003) 18-23
44. Kim S., Lim Y.T., Soltesz E.G., et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22 (2004) 93-97
45. Frangioni J.V., Kim S.W., Ohnishi S., et al. Sentinel lymph node mapping with type-II quantum dots. Methods Mol Biol 374 (2007) 147-159
46. Semenza G.L., Artemov D., Bedi A., et al. 'The metabolism of tumours': 70 years later. Novartis Found Symp 240 (2001) 251-260
47. Cheng Z., Levi J., Xiong Z., et al. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem 17 (2006) 662-669
48. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2 (2002) 683-693
49. Zhang Z., Li H., Liu Q., et al. Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers. Biosens Bioelectron 20 (2004) 643-650
50. Koblinski J.E., Ahram M., and Sloane B.F. Unraveling the role of proteases in cancer. Clin Chim Acta 291 (2000) 113-135
51. Weissleder R., Tung C.H., Mahmood U., et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17 (1999) 375-378
52. Tung C.H., Mahmood U., Bredow S., et al. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60 (2000) 4953-4958
53. Marten K., Bremer C., Khazaie K., et al. Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology 122 (2002) 406-414
54. Grimm J., Kirsch D.G., Windsor S.D., et al. Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc Natl Acad Sci U S A 102 (2005) 14404-14409
55. Figueiredo J.L., Alencar H., Weissleder R., et al. Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int J Cancer 118 (2006) 2672-2677
56. Kirsch D.G., Dinulescu D.M., Miller J.B., et al. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med 13 (2007) 992-997
57. Emmert-Buck M.R., Roth M.J., Zhuang Z., et al. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 145 (1994) 1285-1290
58. Choi Y., Weissleder R., and Tung C.H. Selective antitumor effect of novel protease-mediated photodynamic agent. Cancer Res 66 (2006) 7225-7229
59. Deshane J., Garner C.C., and Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278 (2003) 4135-4144
60. Mamelak A.N., Rosenfeld S., Bucholz R., et al. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol 24 (2006) 3644-3650
61. Veiseh M., Gabikian P., Bahrami S.B., et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 67 (2007) 6882-6888
62. Ballou B., Fisher G.W., Waggoner A.S., et al. Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies. Cancer Immunol Immunother 41 (1995) 257-263
63. Liu T.C., Wang J.H., Wang H.Q., et al. Bioconjugate recognition molecules to quantum dots as tumor probes. J Biomed Mater Res A 83 (2007) 1209-1216
64. Brooks P.C., Clark R.A., and Cheresh D.A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264 (1994) 569-571
65. Wang W., Ke S., Wu Q., et al. Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts. Mol Imaging 3 (2004) 343-351
66. Cai W., Shin D.W., Chen K., et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 6 (2006) 669-676
67. Smith B.R., Cheng Z., De A., et al. Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett 8 (2008) 2599-2606
68. Wu Y., Cai W., and Chen X. Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers. Mol Imaging Biol 8 (2006) 226-236
69. Zhang H., Berezov A., Wang Q., et al. ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117 (2007) 2051-2058
70. Wang J., Yong W.H., Sun Y., et al. Receptor-targeted quantum dots: fluorescent probes for brain tumor diagnosis. J Biomed Opt 12 (2007) 044021
71. Aerts H.J., Dubois L., Hackeng T.M., et al. Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII. Radiother Oncol 83 (2007) 326-332
72. Gleysteen J.P., Newman J.R., Chhieng D., et al. Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck 30 (2008) 782-789
73. Seshadri R., Firgaira F.A., Horsfall D.J., et al. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The south Australian breast cancer study group. J Clin Oncol 11 (1993) 1936-1942
74. Ravdin P.M., and Chamness G.C. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene 159 (1995) 19-27
75. Koyama Y., Hama Y., Urano Y., et al. Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res 13 (2007) 2936-2945
76. Hassan M., Riley J., Chernomordik V., et al. Fluorescence lifetime imaging system for in vivo studies. Mol Imaging 6 (2007) 229-236
77. Lee S.B., Hassan M., Fisher R., et al. Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res 14 (2008) 3840-3849